[{"Assets_0_Q3_USD":4795739.0,"CommonStockSharesOutstanding_0_Q3_shares":12548870.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-3735905.0,"NetIncomeLoss_3_Q3_USD":-5610920.0,"NetIncomeLoss_1_Q3_USD":-3201884.0,"StockholdersEquity_0_Q3_USD":-2315993.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180514"}]